Depression treatment and A dynamics: A study of Alzheimer s disease risk

Go Back to All Clinical Trials

Depression treatment and A dynamics: A study of Alzheimer s disease risk

Brief description of study

The purpose of this research study is to test if a reduction in depressive symptoms in response to treatment with an antidepressant improves levels of certain proteins which have been associated with increased risk for the development of Alzheimer's disease (AD).

Clinical Study Identifier: s21-00535

ClinicalTrials.gov Identifier: NCT05004987

Principal Investigator: Nunzio Pomara.

Other Investigators: Timothy Michael Shepherd, Jaime Ramos Cejudo, Henry Rusinek, Evan G Stein, Michele Santacatterina, Ricardo Miguel Osorio Suarez, Kathy F Yates, Dan Iosifescu.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies